In addition, patients with high-grade (GS 8–10) localized prostate cancer, a PSA of ≤2.5 and 2.5–4 ng/mL was more likely to have cancer-specific death, when compared to PSA levels between 4 and 10 ng/ml (10). This evidence concerns the gene KLK3 and cancer.